Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer.
A phase I dose-escalating study of combination pemetrexed-based chemotherapy and concomitant radiotherapy for locally advanced or metastatic non-small cell lung or esophageal cancer.
Overcoming Barriers to Tobacco Cessation and Lung Cancer Screening among Racial and Ethnic Minority Groups and Underserved Patients in Academic Centers and Community Network Sites: The City of Hope Experience.
ROS1 rearranged non-small cell lung cancer brain metastases respond to low dose radiotherapy.
Phase 2 trial of Linifanib (ABT-869) in patients with advanced non-small cell lung cancer.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase 2 trial of Linifanib (ABT-869) in patients with advanced non-small cell lung cancer.
Phase 2 trial of Linifanib (ABT-869) in patients with advanced non-small cell lung cancer. J Thorac Oncol. 2011 Aug; 6(8):1418-25.
View in:
PubMed
subject areas
Adenocarcinoma
Administration, Oral
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Female
Follow-Up Studies
Humans
Indazoles
International Agencies
Lung Neoplasms
Male
Middle Aged
Neoplasm Staging
Phenylurea Compounds
Receptor Protein-Tyrosine Kinases
Salvage Therapy
Survival Rate
Treatment Outcome
authors with profiles
Clarissa C. Parker
Ravi Salgia
Thomas Hensing